These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 20488307)

  • 1. Characterization of the arrhythmogenic substrate in ischemic and nonischemic cardiomyopathy implications for catheter ablation of hemodynamically unstable ventricular tachycardia.
    Nakahara S; Tung R; Ramirez RJ; Michowitz Y; Vaseghi M; Buch E; Gima J; Wiener I; Mahajan A; Boyle NG; Shivkumar K
    J Am Coll Cardiol; 2010 May; 55(21):2355-65. PubMed ID: 20488307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the arrhythmogenic substrate for ventricular tachycardia in patients with ischemic vs non-ischemic cardiomyopathy - insights from high-density, multi-electrode catheter mapping.
    Kotake Y; Nalliah CJ; Campbell T; Bennett RG; Turnbull S; Kumar S
    J Interv Card Electrophysiol; 2023 Jan; 66(1):5-14. PubMed ID: 34787768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endocardial ablation to eliminate epicardial arrhythmia substrate in scar-related ventricular tachycardia.
    Komatsu Y; Daly M; Sacher F; Cochet H; Denis A; Derval N; Jesel L; Zellerhoff S; Lim HS; Jadidi A; Nault I; Shah A; Roten L; Pascale P; Scherr D; Aurillac-Lavignolle V; Hocini M; Haïssaguerre M; Jaïs P
    J Am Coll Cardiol; 2014 Apr; 63(14):1416-26. PubMed ID: 24486269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endocardial substrate mapping for monomorphic ventricular tachycardia ablation in ischemic and non-ischemic cardiomyopathy.
    Fukuzawa K; Yoshida A; Kubo S; Takano T; Kiuchi K; Kanda G; Takami K; Kumagai H; Torii S; Takami M; Yokoyama M; Hirata K
    Kobe J Med Sci; 2008 Jul; 54(2):E122-35. PubMed ID: 18772614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Image Integration to Guide Catheter Ablation in Scar-Related Ventricular Tachycardia.
    Yamashita S; Sacher F; Mahida S; Berte B; Lim HS; Komatsu Y; Amraoui S; Denis A; Derval N; Laurent F; Sermesant M; Montaudon M; Hocini M; Haïssaguerre M; Jaïs P; Cochet H
    J Cardiovasc Electrophysiol; 2016 Jun; 27(6):699-708. PubMed ID: 26918883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epicardial ablation of ventricular tachycardia: an institutional experience of safety and efficacy.
    Tung R; Michowitz Y; Yu R; Mathuria N; Vaseghi M; Buch E; Bradfield J; Fujimura O; Gima J; Discepolo W; Mandapati R; Shivkumar K
    Heart Rhythm; 2013 Apr; 10(4):490-8. PubMed ID: 23246598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epicardial ventricular tachycardia in ischemic cardiomyopathy: Prevalence, electrophysiological characteristics, and long-term ablation outcomes.
    Hayashi T; Liang JJ; Muser D; Shirai Y; Enriquez A; Garcia FC; Supple GE; Schaller RD; Frankel DS; Lin D; Nazarian S; Zado ES; Arkles JS; Dixit S; Callans DJ; Marchlinski FE; Santangeli P
    J Cardiovasc Electrophysiol; 2018 Nov; 29(11):1530-1539. PubMed ID: 30230120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beyond the Storm: Comparison of Clinical Factors, Arrhythmogenic Substrate, and Catheter Ablation Outcomes in Structural Heart Disease Patients With versus Those Without a History of Ventricular Tachycardia Storm.
    Kumar S; Fujii A; Kapur S; Romero J; Mehta NK; Tanigawa S; Epstein LM; Koplan BA; Michaud GF; John RM; Stevenson WG; Tedrow UB
    J Cardiovasc Electrophysiol; 2017 Jan; 28(1):56-67. PubMed ID: 27781325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epicardial substrate and outcome with epicardial ablation of ventricular tachycardia in arrhythmogenic right ventricular cardiomyopathy/dysplasia.
    Garcia FC; Bazan V; Zado ES; Ren JF; Marchlinski FE
    Circulation; 2009 Aug; 120(5):366-75. PubMed ID: 19620503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the Ventricular Tachycardia Circuit Between Patients With Ischemic and Nonischemic Cardiomyopathies: Detailed Characterization by Entrainment.
    Shirai Y; Liang JJ; Santangeli P; Arkles JS; Schaller RD; Supple GE; Nazarian S; Garcia FC; Lin D; Dixit S; Callans DJ; Marchlinski FE; Frankel DS
    Circ Arrhythm Electrophysiol; 2019 Jul; 12(7):e007249. PubMed ID: 31296041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the arrhythmogenic substrate in patients with arrhythmogenic right ventricular cardiomyopathy undergoing ventricular tachycardia ablation.
    Kirubakaran S; Bisceglia C; Silberbauer J; Oloriz T; Santagostino G; Yamase M; Maccabelli G; Trevisi N; Della Bella P
    Europace; 2017 Jun; 19(6):1049-1062. PubMed ID: 28371837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epicardial ventricular tachycardia substrate visualized by magnetic resonance imaging: need for a transpericardial ablation approach?
    Reithmann C; Herkommer B; Fiek M
    Clin Res Cardiol; 2016 Oct; 105(10):827-37. PubMed ID: 27294860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relation of the unipolar low-voltage penumbra surrounding the endocardial low-voltage scar to ventricular tachycardia circuit sites and ablation outcomes in ischemic cardiomyopathy.
    Chopra N; Tokuda M; Ng J; Reichlin T; Nof E; John RM; Tedrow UB; Stevenson WG
    J Cardiovasc Electrophysiol; 2014 Jun; 25(6):602-8. PubMed ID: 24576211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of Structural Changes in Arrhythmogenic Right Ventricular Cardiomyopathy With Recurrent Ventricular Tachycardia After Ablation: Insights From Repeat Electroanatomic Voltage Mapping.
    Briceño DF; Liang JJ; Shirai Y; Markman TM; Chahal A; Tschabrunn C; Zado E; Hyman MC; Kumareswaran R; Arkles JS; Santangeli P; Schaller RD; Supple GE; Frankel DS; Deo R; Riley MP; Nazarian S; Lin D; Epstein AE; Garcia FC; Dixit S; Callans DJ; Marchlinski FE
    Circ Arrhythm Electrophysiol; 2020 Jan; 13(1):e007611. PubMed ID: 31922914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value of high-density endocardial and epicardial mapping for catheter ablation of hemodynamically unstable ventricular tachycardia.
    Cesario DA; Vaseghi M; Boyle NG; Fishbein MC; Valderrábano M; Narasimhan C; Wiener I; Shivkumar K
    Heart Rhythm; 2006 Jan; 3(1):1-10. PubMed ID: 16399044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-Term Outcome After Ventricular Tachycardia Ablation in Nonischemic Cardiomyopathy: Late Potential Abolition and VT Noninducibility.
    Okubo K; Gigli L; Trevisi N; Foppoli L; Radinovic A; Bisceglia C; Frontera A; D'Angelo G; Cireddu M; Paglino G; Mazzone P; Della Bella P
    Circ Arrhythm Electrophysiol; 2020 Aug; 13(8):e008307. PubMed ID: 32657137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of ripple mapping for identification of slow conduction channels during ventricular tachycardia ablation in the setting of arrhythmogenic right ventricular cardiomyopathy.
    Xie S; Kubala M; Liang JJ; Yang J; Desjardins B; Santangeli P; van der Geest RJ; Schaller R; Riley M; Supple G; Frankel DS; Callans D; Pac EZ; Marchlinski F; Nazarian S
    J Cardiovasc Electrophysiol; 2019 Mar; 30(3):366-373. PubMed ID: 30575168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-analysis comparing outcomes of catheter ablation for ventricular arrhythmia in ischemic versus nonischemic cardiomyopathy.
    Basu-Ray I; Khanra D; Shah SK; Mukherjee A; Char SV; Jain B; Bunch TJ; Gold M; Adeboye AA; Saeed M
    Pacing Clin Electrophysiol; 2021 Jan; 44(1):54-62. PubMed ID: 33216394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined endo- and epicardial pace-mapping to localize ventricular tachycardia isthmus in ischaemic and non-ischaemic cardiomyopathy.
    Hanaki Y; Komatsu Y; Nogami A; Kowase S; Kurosaki K; Sekiguchi Y; Aonuma K; Ieda M
    Europace; 2022 Apr; 24(4):587-597. PubMed ID: 34543395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epicardial ventricular tachycardia ablation a multicenter safety study.
    Sacher F; Roberts-Thomson K; Maury P; Tedrow U; Nault I; Steven D; Hocini M; Koplan B; Leroux L; Derval N; Seiler J; Wright MJ; Epstein L; Haissaguerre M; Jais P; Stevenson WG
    J Am Coll Cardiol; 2010 May; 55(21):2366-72. PubMed ID: 20488308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.